WallStSmart
CNTA

Centessa Pharmaceuticals PLC ADR

NASDAQ: CNTA · HEALTHCARE · BIOTECHNOLOGY

$39.45
-0.03% today

Updated 2026-04-29

Market cap
$6.10B
P/E ratio
P/S ratio
406.76x
EPS (TTM)
$-1.46
Dividend yield
52W range
$11 – $40
Volume
3.0M

Centessa Pharmaceuticals PLC ADR (CNTA) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
-0.3%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+42.9%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+0.4%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
-3.8%
2025-11-05
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-26$-0.48-24.9%$28.22$28.70+1.7%
2025-11-05$-0.41-5.6%$23.74$22.84-3.8%
2025-08-12$-0.38-15.3%$16.61$17.14+3.2%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.38$-0.48-24.9%
2025-09-30$-0.39$-0.41-5.6%
2025-06-30$-0.33$-0.38-15.3%
2025-03-31$-0.36$-0.20+44.4%$15.00M
2024-12-31$-0.42$-0.84-100.0%$952252.00-86.1%
2024-09-30$-0.40$-0.37+6.6%
2024-06-30$-0.39$-0.40-2.6%
2024-03-31$-0.42$-0.38+9.5%
2023-12-31$-0.48$-0.38+20.8%$6.85M
2023-09-30$-0.52$-0.40+23.1%
2023-06-30$-0.49$-0.26+46.9%

Frequently asked questions

Has Centessa Pharmaceuticals PLC ADR beaten earnings estimates?
Centessa Pharmaceuticals PLC ADR has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of -0.3% over the last 4 quarters.
How does CNTA stock react to earnings?
CNTA stock has moved an average of +0.4% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.